Location History:
- Koln, DE (1996 - 2000)
- Köln, DE (2001 - 2019)
- Cologne, DE (1991 - 2024)
Company Filing History:
38 out of 12,160 
7 out of 21 
3 out of 721 
Years Active: 1991-2025
Areas of Expertise:
Title: Winfried Joentgen: A Prolific Innovator and Patent Holder
Introduction:
Winfried Joentgen, hailing from Koln, Germany, is a renowned inventor and patent holder with an impressive track record in the field of pharmaceutical research. With a staggering number of 46 patents to his name, Joentgen's contributions have been instrumental in advancing the pharmaceutical industry. In this article, we will delve into some of his latest patents, career highlights, collaborations, and conclude with an appreciation of his remarkable achievements.
Latest Patents:
One of Joentgen's recent groundbreaking inventions is related to forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate. This invention encompasses various modifications, including Modification I, Modification II, mono-DMSO solvate, sesqui-DMSO solvate, and β-ethyl acetate solvate. These forms have immense potential in pharmaceutical applications, offering diverse options for drug delivery and efficacy.
Career Highlights:
Throughout his illustrious career, Joentgen has made significant contributions to the pharmaceutical industry through his work with prestigious companies such as Bayer Aktiengesellschaft and Adverio Pharma GmbH. His expertise and passion for innovation have been fundamental in driving groundbreaking research and development initiatives within these organizations. Joentgen's patents are a testament to his commitment to advancing drug discovery and improving patient care.
Collaborations:
Collaboration has been a cornerstone of Joentgen's success, and his fruitful collaborations with colleagues highlight his ability to work effectively in multidisciplinary teams. Two notable coworkers who have worked alongside Joentgen are Torsten Groth and Paul Wagner. Together, they have shared their knowledge and expertise, fostering an environment conducive to innovation and shared success.
Conclusion:
Winfried Joentgen's extensive patent portfolio and contributions to the pharmaceutical industry reflect his profound influence on drug development and patient care. His latest inventions, particularly the forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate, demonstrate his commitment to pushing the boundaries of pharmaceutical research. As Joentgen continues to make valuable contributions to the field, we can anticipate further advancements in drug delivery and therapeutic efficacy. The innovation and dedication demonstrated by Joentgen serve as an inspiration for aspiring inventors and scientists alike.
If you would like to know more about Winfried Joentgen or any other inventors, companies, or patents, you can visit our website, idiyas.com, to explore a wealth of information on innovations and patents.